Coya Therapeutics Inc logo

Coya Therapeutics Inc

NAS:COYA (USA)  
1
$ 4.06 +0.035 (+0.87%) 11:10 PM EST
P/E:
At Loss
P/B:
0
Market Cap:
$ 40.26M
Enterprise V:
$ 52.25M
Volume:
11.99K
Avg Vol (2M):
23.30K
Volume:
11.99K
Market Cap $:
40.26M
PE Ratio:
At Loss
Avg Vol (2M):
23.30K
Enterprise Value $:
52.25M
PB Ratio:
0

Business Description

Compare
Compare
Traded in other countries / regions
COYA.USA
IPO Date
2022-12-29
Description
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
Name Current Vs Industry Vs History
Cash-To-Debt 0.73
Equity-to-Asset -0.59
Debt-to-Equity -2.21
Debt-to-EBITDA -7.36
Interest Coverage N/A
N/A
N/A
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 33.27
9-Day RSI 37.76
14-Day RSI 41.37

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.38
Quick Ratio 3.38
Cash Ratio 3.36

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
ROA % -23.53
ROIC % -564.66
ROC (Joel Greenblatt) % -1466.06
ROCE % -31.98

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -32.25
EV-to-EBITDA -32.47
EV-to-FCF -51.38
Earnings Yield (Greenblatt) % -3.1

Financials

COYA's 30-Y Financials

How Coya Therapeutics Inc (COYA) Makes Its Money

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:COYA

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
To

Annualized Return %

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Executives

Details

Valuation chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.249
Beta 0
Volatility % 0
14-Day RSI 41.37
14-Day ATR ($) 0.361287
20-Day SMA ($) 4.358125
12-1 Month Momentum % 0
52-Week Range ($) 3.685 - 5.67
Shares Outstanding (Mil) 9.92

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Coya Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Coya Therapeutics Inc Stock Events

Event Date Price($)
No Event Data

Coya Therapeutics Inc Frequently Asked Questions

What is Coya Therapeutics Inc(COYA)'s stock price today?
The current price of COYA is $4.06. The 52 week high of COYA is $5.67 and 52 week low is $3.69.
When is next earnings date of Coya Therapeutics Inc(COYA)?
The next earnings date of Coya Therapeutics Inc(COYA) is .
Does Coya Therapeutics Inc(COYA) pay dividends? If so, how much?
Coya Therapeutics Inc(COYA) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1